A comparison of therapeutic trends in myocardial infarction

Wien Klin Wochenschr. 2007;119(11-12 Suppl 1):15-9.

Authors

D Milasinovic¹, L Teischinger, G Luerzer, W Mohl

Affiliation

¹ Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria.

PMID: 19618592

No abstract available

Publication types

Review

MeSH terms

Abciximab
Angioplasty, Balloon, Coronary / methods*
Antibodies, Monoclonal / administration & dosage
Atherectomy, Coronary / methods
Combined Modality Therapy
Drug-Eluting Stents*
Hospital Mortality
Humans
Immunoglobulin Fab Fragments / administration & dosage
Mineralocorticoid Receptor Antagonists
Myocardial Infarction / mortality
Myocardial Infarction / therapy*
Myocardial Revascularization / methods*
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
Thrombolytic Therapy / methods*

Substances

Antibodies, Monoclonal
Immunoglobulin Fab Fragments
Mineralocorticoid Receptor Antagonists
Platelet Glycoprotein GPIIb-IIIa Complex
Abciximab